Download full report with analyst certification and important disclosures
Jul 30 2026, 08:09 IST/BST
Better-than-expected margin and sales delivery for Taste, Nutrition & Health (TNH) supported an EBITDA beat at group level in the period. Pet activities were back in Q2 but are expected to gradually improve through H2, while Scent & Care benefitted from a strong Q2 performance in Consumer Fragrance – helping to offset negative growth for Fine Fragrance. Cash conversion stepped up materially and provides confidence for full-year delivery. Overall, Symrise is on track to meet full-year expectations.
Jul 30 2026, 08:09 IST/BST